Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Aspect-based drug review classification through a hybrid model with ant colony optimization using deep learning
in
Ant colony optimization
/ Data mining
/ Datasets
/ Deep learning
/ Drugs
/ Effectiveness
/ Health care
/ Pharmaceutical industry
/ Pharmaceuticals
/ Pharmacovigilance
/ Sentiment analysis
2024
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Aspect-based drug review classification through a hybrid model with ant colony optimization using deep learning
by
in
Ant colony optimization
/ Data mining
/ Datasets
/ Deep learning
/ Drugs
/ Effectiveness
/ Health care
/ Pharmaceutical industry
/ Pharmaceuticals
/ Pharmacovigilance
/ Sentiment analysis
2024
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Aspect-based drug review classification through a hybrid model with ant colony optimization using deep learning
in
Ant colony optimization
/ Data mining
/ Datasets
/ Deep learning
/ Drugs
/ Effectiveness
/ Health care
/ Pharmaceutical industry
/ Pharmaceuticals
/ Pharmacovigilance
/ Sentiment analysis
2024
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Aspect-based drug review classification through a hybrid model with ant colony optimization using deep learning
Journal Article
Aspect-based drug review classification through a hybrid model with ant colony optimization using deep learning
2024
Request Book From Autostore
and Choose the Collection Method
Overview
The task of aspect-level sentiment analysis is intricately designed to determine the sentiment polarity directed towards a specific target within a sentence. With the increasing availability of online reviews and the growing importance of healthcare decisions, analyzing drug reviews has become a critical task. Traditional sentiment analysis, which categorizes a whole review as positive, negative, or neutral, provides limited insights for consumers and healthcare professionals. Aspect-based sentiment analysis (ABSA) aims to overcome these limitations by identifying and evaluating the sentiment associated with specific aspects or attributes of drugs mentioned in the reviews. Various fields, including business, politics, and medicine, have been explored in the context of sentiment analysis. Automation of online user reviews allows pharmaceutical companies to assess large amounts of user feedback. This helps extract pharmacological efficacy and side effect insights. The data collected could improve pharmacovigilance. Reviewing user comments can provide valuable data that can be used to improve drug safety and efficacy monitoring procedures. This improves pharmacovigilance processes, improving pharmaceutical outcomes understanding and corporate decision-making. Therefore, we propose a pre-trained RoBERTa with a Bi-LSTM model to categorise drug reviews from online sources and pre-process the text data. Ant Colony Optimization can be used in feature selection for ABSA, helping to identify the most relevant aspects and sentiments. Further, RoBERTa is fine-tuned to perform ABSA on the dataset, enabling the system to categorize aspects and determine the associated sentiment. The outcomes reveal that the suggested framework has achieved higher accuracy (96.78%) and F1 score (98.29%) on druglib.com, and 95.02% on the drugs.com dataset, than several prior state-of-the-art methods.
Publisher
Springer Nature B.V
This website uses cookies to ensure you get the best experience on our website.